EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Discovery of a novel natural compound, vitekwangin B, with ANO1 protein reduction properties and anticancer potential

Yohan Seo, Sion Lee, Minuk Kim, Dongguk Kim, Sung Baek Jeong, Raju Das, Armin Sultana, SeonJu Park, Nguyen Xuan Nhiem, Phan Thi Thanh Huong, Oh-Bin Kwon, Wan Namkung und 1 weitere

Frontiers in Pharmacology · 03.04.2024 · 15

DOI: 10.3389/fphar.2024.1382787 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 03.04.2024. Verfasst von Yohan Seo und 12 weiteren Autor:innen. Beteiligte Einrichtung: New Drug Development Center, Daegu Gyeongbuk Medical Innovation Foundation (KMEDIhub), Daegu, Republic of Korea. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Prostate cancer and non-small cell lung cancer (NSCLC) present significant challenges in the development of effective therapeutic strategies. Hormone therapies for prostate cancer target androgen receptors and prostate-specific antigen markers. However, treatment options for prostatic small-cell neuroendocrine carcinoma are limited. NSCLC, on the other hand, is primarily treated with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors but exhibits resistance. This study explored a novel therapeutic approach by investigating the potential anticancer properties of vitekwangin B, a natural compound derived from Vitex trifolia .

Methods

Vitekwangin B was chromatographically isolated from the fruits of V. trifolia . ANO1 protein levels in prostate cancer and NSCLC cells were verified and evaluated again after vitekwangin B treatment.

Results

Vitekwangin B did not inhibit anoctamin1 (ANO1) channel function but significantly reduced ANO1 protein levels. These results demonstrate that vitekwangin B effectively inhibited cancer cell viability and induced apoptosis in prostate cancer and NSCLC cells. Moreover, it exhibited minimal toxicity to liver cells and did not affect hERG channel activity, making it a promising candidate for further development as an anticancer drug.

Conclusion

Vitekwangin B may offer a new direction for cancer therapy by targeting ANO1 protein, potentially improving treatment outcomes in patients with prostate cancer and NSCLC. Further research is needed to explore its full potential and overcome existing drug resistance challenges.

Schlagwörter

Stichwörter der Autor:innen

anoctamin 1apoptosislung cancerprostate cancerprotein reductionvitekwangin B

Autor:innen und Institutionen

  • New Drug Development Center, Daegu Gyeongbuk Medical Innovation Foundation (KMEDIhub), Daegu, Republic of Korea.
  • Department of Medical Device Development Center, Daegu-Gyeongbuk Medical Innovation Foundation (KMEDI Hub), Daegu, Republic of Korea.
  • Department of Physiology, Dongguk University College of Medicine, Gyeongju, Republic of Korea.
  • Metropolitan Seoul Center, Korea Basic Science Institute (KBSI), Seoul, Republic of Korea.
  • Institute of Marine and Biochemistry, Vietnam Academy of Science and Technology (VAST), Hanoi, Vietnam.
  • College of Pharmacy, Yonsei Institute of Pharmaceutical Science, Yonsei University, Incheon, Republic of Korea.

Zitieren

APA

Seo, Y., Lee, S., Kim, M., Kim, D., Jeong, S. B., Das, R., Sultana, A., Park, S., Nhiem, N. X., Huong, P. T. T., Kwon, O. B., Namkung, W., & Woo, J. (2024). Discovery of a novel natural compound, vitekwangin B, with ANO1 protein reduction properties and anticancer potential. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1382787

Vancouver

Seo Y, Lee S, Kim M, Kim D, Jeong SB, Das R, et al. Discovery of a novel natural compound, vitekwangin B, with ANO1 protein reduction properties and anticancer potential. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1382787

BibTeX
@article{Seo2024,
  author = {Seo, Yohan and Lee, Sion and Kim, Minuk and Kim, Dongguk and Jeong, Sung Baek and Das, Raju and Sultana, Armin and Park, SeonJu and Nhiem, Nguyen Xuan and Huong, Phan Thi Thanh and Kwon, Oh-Bin and Namkung, Wan and Woo, Joohan},
  title = {Discovery of a novel natural compound, vitekwangin B, with ANO1 protein reduction properties and anticancer potential},
  journal = {Frontiers in Pharmacology},
  year = {2024},
  volume = {15},
  doi = {10.3389/fphar.2024.1382787}
}
Kostenlos starten →